Brookfield Corporation (BN)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 51.46 |
|---|---|
| 52-week range | 50.76 – 68.08 |
| Return, 1 month / 3 months | −1.2% / −15.7% |
| Return, 1 year / 3 years | −16.3% / +79.3% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 27.2% |
| Worst drawdown (1 year) | -24.3% |
| Average daily value traded | 181.53M CAD |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Brookfield Corporation is a Canadian holding company based in Toronto that owns and manages a broad range of assets on behalf of institutional and individual investors. Its activities span real estate, renewable power, infrastructure and private equity, with operations across many countries. The company invests its own capital alongside that of its clients and partners, and it manages funds and portfolios focused on long-lived assets that generate steady cash flows over time.
The shares are listed on the Toronto Exchange in Canada under the code BN, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Brookfield Corporation (BN) trades on the Toronto Exchange in Canada. It last closed at CAD 51.46 on 19 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 503 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.3% and over the last three months it fell 15.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 29 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.6% | ||
| From 52-week high | -23.8% | ||
| Momentum | 21 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.7% | ||
| 6-month return | -19.1% | ||
| 12-month return, skipping the last month | -15.2% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.3% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 181.53M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −1.2% |
| 3 months | −15.7% |
| 6 months | −19.1% |
| 1 year | −16.3% |
| 3 years | +79.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 54.91 / 59.53 |
|---|---|
| Golden / death cross (60 days) | Death, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 1.07 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | CAD 0.0970 |
| 15 Jun 2026 | CAD 0.0980 |
| 17 Mar 2026 | CAD 0.0960 |
| 16 Dec 2025 | CAD 0.0825 |
| 12 Sep 2025 | CAD 0.1246 |
| 13 Jun 2025 | CAD 0.1224 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.